Legal & General Group’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.54M | Buy |
75,391
+8,808
| +13% | +$414K | ﹤0.01% | 1703 |
|
2025
Q1 | $2.94M | Buy |
66,583
+818
| +1% | +$36.1K | ﹤0.01% | 1775 |
|
2024
Q4 | $2.38M | Buy |
65,765
+6,468
| +11% | +$234K | ﹤0.01% | 1904 |
|
2024
Q3 | $1.9M | Buy |
59,297
+1,199
| +2% | +$38.4K | ﹤0.01% | 1995 |
|
2024
Q2 | $2.19M | Buy |
58,098
+7,285
| +14% | +$274K | ﹤0.01% | 1907 |
|
2024
Q1 | $2.5M | Buy |
50,813
+1,144
| +2% | +$56.3K | ﹤0.01% | 1836 |
|
2023
Q4 | $1.81M | Buy |
49,669
+12,055
| +32% | +$440K | ﹤0.01% | 1996 |
|
2023
Q3 | $870K | Sell |
37,614
-437
| -1% | -$10.1K | ﹤0.01% | 2233 |
|
2023
Q2 | $998K | Buy |
38,051
+4,240
| +13% | +$111K | ﹤0.01% | 2227 |
|
2023
Q1 | $870K | Buy |
33,811
+9,190
| +37% | +$237K | ﹤0.01% | 2183 |
|
2022
Q4 | $640K | Sell |
24,621
-2,274
| -8% | -$59.1K | ﹤0.01% | 2276 |
|
2022
Q3 | $767K | Sell |
26,895
-1,534
| -5% | -$43.7K | ﹤0.01% | 2227 |
|
2022
Q2 | $700K | Buy |
28,429
+6,660
| +31% | +$164K | ﹤0.01% | 2264 |
|
2022
Q1 | $1.23M | Buy |
21,769
+3
| +0% | +$169 | ﹤0.01% | 2166 |
|
2021
Q4 | $1.35M | Buy |
21,766
+51
| +0.2% | +$3.16K | ﹤0.01% | 2164 |
|
2021
Q3 | $1.38M | Buy |
21,715
+3,829
| +21% | +$243K | ﹤0.01% | 2157 |
|
2021
Q2 | $1.47M | Buy |
17,886
+3,720
| +26% | +$307K | ﹤0.01% | 2099 |
|
2021
Q1 | $1.04M | Buy |
14,166
+10,635
| +301% | +$783K | ﹤0.01% | 2181 |
|
2020
Q4 | $256K | Buy |
3,531
+418
| +13% | +$30.3K | ﹤0.01% | 2371 |
|
2020
Q3 | $148K | Sell |
3,113
-936
| -23% | -$44.5K | ﹤0.01% | 2410 |
|
2020
Q2 | $170K | Buy |
4,049
+2,508
| +163% | +$105K | ﹤0.01% | 2394 |
|
2020
Q1 | $41K | Sell |
1,541
-23,330
| -94% | -$621K | ﹤0.01% | 2668 |
|
2019
Q4 | $954K | Buy |
24,871
+24,676
| +12,654% | +$947K | ﹤0.01% | 2078 |
|
2019
Q3 | $4K | Buy |
+195
| New | +$4K | ﹤0.01% | 3335 |
|